Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: A placebo-controlled study

American Journal of Clinical Dermatology

Volumn 8, Issue 4, 2007, Pages 235-238

  Cömert, Asuman ^a,c   Bekiroglu, Nural ^b   Gürb̈uz, Oya ^b   Ergun, T̈ulin ^b  

^a MALTEPE UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PLACEBO;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PRURITUS; SEBORRHEIC DERMATITIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; DERMATITIS, SEBORRHEIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUCONAZOLE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34547608148     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200708040-00005     Document Type: Article

References (34)

1. Plewig G, Jansen T. Seborrhoeic dermatitis. In: Fitzpatrick TB, Wollf K, Eisen AZ, et al., editors. Dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999: 1482-9
2. Bergbrant IM. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunologic and clinical studies. Acta Derm Venereol 1991; Suppl. 167: 10-36
3. Gueho E, Boekhout T, Ashbee HR, et al. The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol 1998; 36 Suppl. 1: 220-9
4. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235-42
5. Faergemann J, Jones TC, Hettler O, et al. P. ovale (M. furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996; 134 Suppl. 46: 12-5
6. Heng MCY, Henderson CL, Barker DC, et al. Correlation of Pityrosporum ovale density with clinical severity of seborrhoeic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990; 23: 82-6
7. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695-700
8. Robert A, Schwartz MPH, Christopher AJ, et al. Seborrheic dermatitis: an overview. Am Fam Physician 2006; 74: 125-30
9. Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology 2004; 208: 89-93
10. Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol 2004; 5 (6): 417-22
11. Gunduz K, Inanir I, Sacar H. Efficacy of terbinafine 1% cream on seborrheic dermatitis. J Dermatol 2005; 32 (1): 22-5
12. Skinner RB, Noah PW, Taylor RM. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 12: 852-6
13. Faergemann J, Borgers M. The effect of ketoconazole and itraconazole on the filamentous form of P. ovale. Acta Derm Venereol 1990; 70: 172-6
14. Danby FW, Maddin WS, Margesson LJ, et al. A randomized, double-blind placebo-controlled trial of ketoconazole 2% shampoo vs. selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993; 29: 1008-12
15. Ford GP, Farr PM, Ive FA, et al. The response of seborrheic dermatitis to ketoconazole. Br J Dermatol 1984; 111: 603-7
16. Köse O, Erbil H, Gür AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, non-comparative trial. J Eur Acad Dermatol Venereol 2005; 19: 172-5
17. Parsad D, Pandhi R, Negi KS, et al. Topical metronidazole in seborrheic dermatitis: a double-blind study. Dermatology 2001; 202: 35-7
18. Rigopoulos D, Katsambas A, Antoniou C, et al. Facial seborrheic dermatitis treated with fluconazole 2% shampoo. Int J Dermatol 1994; 33 (2): 136-7
19. Boyle J, Burton JL, Faergemann J. The use of topical lithium succinate for seborrheic dermatitis [letter]. BMJ 1986; 292: 28
20. Scaparro E, Quadr G, Virno G, et al. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrheic dermatitis: a multicenter, randomized, investigator-blinded placebo-controlled trial. Br J Dermatol 2001; 144: 854-7
21. Debruyne D. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses. Clin Pharmacokinet 1997; 33: 52-77
22. Pierard-Franchimont C, Pierard GE, Arrese JE, et al. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001; 202: 171-6
23. Baroni A, Rosa RDE, De Rosa A, et al. New strategies in dandruff therapy: growth control of M. ovale. Dermatology 2000; 201: 332-6
24. Van Cutsem J, Van Gerven F, Van Cauwenbergh G, et al. The anti-inflammatory effect of ketoconazole: a comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea pigs. J Am Acad Dermatol 1991; 25: 257-61
25. Rosen T, Schell BJ, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol 1997; 36: 788-92
26. Camera E, Cannistraci C, Briganti S, et al. Scavenging effects of terbinafine on free radicals in vitro. Br J Dermatol 1999; 140: 640-4
27. Bodey GP. Azole antifungal agents. Clin Infect Dis 1992; 14: 161-9
28. Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol 1992; 72: 74-5
29. Montero-Gei F, Perera A. Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis. Clin Infect Dis 1992; 14 Suppl. 1: 77-81
30. Zisova LG. Fluconazole and its place in the treatment of seborrheic dermatitis: new therapeutic possibilities. Folia Med (Plovdiv) 2006; 48 (1): 39-45
31. Karakaş M, Durdu M, Memişoglu HR. Oral fluconazole in the treatment of tinea versicolor. J Dermatol 2005 Jan; 32 (1): 19-21
32. Farschian M, Yaghoobi R, Samadi K. Fluconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatolog Treat 2002 Jun; 13 (2): 73-6
33. Coldiron B. Recalcitrant onychomycosis of the toenails successfully treated with fluconazole. Arch Dermatol 1992; 128: 909-10
34. Montero-Gei F. Fluconazole in the treatment of severe onychomycosis. Int J Dermatol 1996; 35: 587-8